Cytoreductive surgery
Cytoreductive surgery is a medical procedure with 34 clinical trials. Currently 8 active trials ongoing. Historical success rate of 87.5%.
Success Metrics
Based on 14 completed trials
Phase Distribution
Phase Distribution
8
Early Stage
13
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
77.8%
14 of 18 finished
22.2%
4 ended early
8
trials recruiting
34
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
Validation of ESGO Quality Indicators in Advanced Ovarian Cancer Surgery
Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer
Clinical Trials (34)
Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
Validation of ESGO Quality Indicators in Advanced Ovarian Cancer Surgery
Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer
ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis
A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer
CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma
Efficacy of the Use of Neoadjuvant With/Without Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Advanced Colon Cancer
Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Primary Tumor Resection With Sintilimab and Chemotherapy in Advanced NSCLC
Secondary Interval Cytoreductive Surgery in Platinum-sensitive Recurrent Epithelial Ovarian Cancer
Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients
Preoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the Liver
Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin
Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis
SUROVA - Surgery in Ovarian Cancer, Comparing Primary and Interval Cytoreductive Surgery
Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer
Assessment of Quality of Life After Low Anterior Resection During Cytoreductive Surgery for Advanced Ovarian Cancer
EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 34